7 research outputs found

    An Adaptive Scheduling Algorithm for Dynamic Jobs for Dealing with the Flexible Job Shop Scheduling Problem

    Get PDF
    Modern manufacturing systems build on an effective scheduling scheme that makes full use of the system resource to increase the production, in which an important aspect is how to minimize the makespan for a certain production task (i.e., the time that elapses from the start of work to the end) in order to achieve the economic profit. This can be a difficult problem, especially when the production flow is complicated and production tasks may suddenly change. As a consequence, exact approaches are not able to schedule the production in a short time. In this paper, an adaptive scheduling algorithm is proposed to address the makespan minimization in the dynamic job shop scheduling problem. Instead of a linear order, the directed acyclic graph is used to represent the complex precedence constraints among operations in jobs. Inspired by the heterogeneous earliest finish time (HEFT) algorithm, the adaptive scheduling algorithm can make some fast adaptations on the fly to accommodate new jobs which continuously arrive in a manufacturing system. The performance of the proposed adaptive HEFT algorithm is compared with other state-of-the-art algorithms and further heuristic methods for minimizing the makespan. Extensive experimental results demonstrate the high efficiency of the proposed approach

    Stroke genetics informs drug discovery and risk prediction across ancestries

    Get PDF
    Previous genome-wide association studies (GWASs) of stroke — the second leading cause of death worldwide — were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis3, and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach4, we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry5. Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries

    Slow dynamics in a quasi-two-dimensional binary complex plasma

    Get PDF
    Slow dynamics in an amorphous quasi-two-dimensional complex plasma, comprised of microparticles of two different sizes, was studied experimentally. The motion of individual particles was observed using video microscopy, and the self-part of the intermediate scattering function as well as the mean-squared particle displacement was calculated. The long-time structural relaxation reveals the characteristic behavior near the glass transition. Our results suggest that binary complex plasmas can be an excellent model system to study slow dynamics in classical supercooled fluids

    Stroke genetics informs drug discovery and risk prediction across ancestries

    No full text
    corecore